Maria Monroe-DeVita, PhD

Personal Statement

My expertise is in implementation and services research related to evidence-based practices (EBPs) for adults with serious mental illness, particularly the Assertive Community Treatment (ACT) model. I am the lead author of the new ACT fidelity tool – the Tool for Measurement of Assertive Community Treatment (TMACT) – which has been widely disseminated nationally and in several other countries. I am also working to develop novel approaches to better addressing the needs of people with serious mental illness in the community. In 2010, I received a collaborative R34 from the National Institute of Mental Health (NIMH) to integrate another EBP, Illness Management and Recovery (IMR) within ACT. I am also working with a national team of clinicians, policymakers and researchers to develop better approaches to address the primary care needs of people with serious mental illness, including those served on ACT teams.

I have served as the Principal Investigator (PI) on several statewide implementation projects with the Washington State Division of Behavioral Health and Recovery, including the development, implementation, and fidelity assessment of 10 new ACT teams, and several IMR and Integrated Dual Disorder Treatment (IDDT) pilots across the state. I am also the PI of a statewide learning collaborative focused on implementation of cognitive behavioral therapy for psychosis (CBTp) for clinicians and supervisors across Washington State. I have an interest in implementation science and serve as a Co-Investigator of the Society for Implementation Research Collaboration (SIRC), an NIMH-funded grant focused on collaborative approaches to implementation research and the dissemination of those findings more broadly to those who implement and sustain EBPs.  More recently, I began work collaboratively with a team of researchers to better address staff burnout prevention and the linkage to client outcomes.

Department Affiliations

Recent Publications

Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study.
(2024 Sep 23)
Psychiatr Serv
Bareis N, Edlund M, Ringeisen H, Guyer H, Dixon LB, Olfson M, Smith TE, Chwastiak L, Monroe-DeVita M, Swartz M, Swanson J, Sinclair Hancq E, Geiger P, Kreski NT, Stroup TS

Clinical characteristics and functioning of adults with bipolar I disorder: Evidence from the mental and substance use disorders prevalence study.
(2024 Dec 1)
J Affect Disord 366(): 317-325
Bareis N, Olfson M, Dixon LB, Chwastiak L, Monroe-Devita M, Kessler RC, Gibbons RD, Edlund M, Guyer H, Kreski NT, Graupensperger S, Winans KS, Stroup TS

Differences in self-reported disruptions in mental health treatment during COVID-19 in a national household sample: impact of severity of functional impairment.
(2024 Jul 29)
Res Sq
Wang M, Graupensperger S, Olfson M, Bareis N, Edlund M, Monroe-DeVita M, Kessler R, Tennison M, Winans K, Chwastiak L

Differences in self-reported disruptions in mental health treatment between SMI and non-SMI groups during COVID-19 in a national household sample.
(2024 Nov-Dec)
Gen Hosp Psychiatry 91(): 237-239
Wang MZ, Graupensperger S, Olfson M, Bareis N, Edlund M, Monroe-DeVita M, Kessler R, Tennison M, Winans K, Chwastiak L

Supporting psychosis research, implementation, and training through an academic intermediary-purveyor organization.
(2024 Nov)
Psychol Serv 21(4): 916-927
Kopelovich SL, Brian RM, Vaswani-Bye A, Chwastiak L, McCain C, Shepard V, Zhang W, Tennison M, Fikre S, Monroe-DeVita M

Show complete publication list »
Edit Profile